China 360-97-4 Factory

We aim to understand high quality disfigurement through the output and supply the most beneficial support to domestic and overseas buyers wholeheartedly for 360-97-4,CAS NO 360-97-4,Dacarbazine intermediate,Dacarbazine advance intermediate,Temozolomide intermediate, For additional information and facts, please speak to us as quickly as possible!
360-97-4 Lamp, Due to the stability of our products, timely supply and our sincere service, we are able to sell our goods not only over the domestic market, but also exported to countries and regions, including the Middle East, Asia, Europe and other countries and regions. At the same time, we also undertake OEM and ODM orders. We'll do our best to serve your company, and establish a successful and friendly cooperation with you.

Hot Products

  • (5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone

    (5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone

    Product Name:(5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone CAS NO:461432-22-4
    Molecular Formula:C15H12BrClO2
    Formula Weight:339.61
    Usage:Dapagliflozin Intermediates​
  • 2,4-Difluorobenzotrifluoride

    2,4-Difluorobenzotrifluoride

    Product Name:2,4-Difluorobenzotrifluoride
    Molecular Formula:C7H3F5
    Molecular Weight:182.09
    CAS Registry Number:64248-61-9
  • Hydriodic acid

    Hydriodic acid

    Product Name:Hydriodic acid
    Molecular Formula:HI
    Molecular Weight:127.91
    CAS Registry Number:10034-85-2
  • Ramipril

    Ramipril

    Product Name:Ramipril
    Molecular Formula:C23H32N2O5
    Molecular Weight;416.51
    CAS Registry Number;87333-19-5
  • 1-Fluoronaphthalene

    1-Fluoronaphthalene

    Product Name:1-Fluoronaphthalene
    Molecular Formula:C10H7F
    Molecular Weight:146.16
    CAS Registry Number:321-38-0
  • Furosemide Injection

    Furosemide Injection

    Product Name:Furosemide Injection
    Dosage:20mg/2ml
    Application:Diuretic

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept